%20(3).gif)
Agentic AI built for clinical development
The only agentic AI platform designed from the ground up for GxP-regulated environments. Model-agnostic. Human-in-the-loop. Connected to 15+ clinical and enterprise systems without replacing any of them.
- Full observability: Transparent, explainable, auditable decision trails
- Connected to your systems: Veeva, Oracle, Medidata, MS 365, Snowflake, and more
- GxP-ready by design: 21 CFR Part 11, Annex 11, ICH GCP, ALCOA+ audit trails
- Human-in-the-loop: Configurable oversight and escalation for every workflow
- Model-agnostic flexibility: Not locked into a single AI provider
Connects to the systems you already use
Over 30 secure, validated connectors to the systems you already run on, from Veeva, Oracle, and Medidata to Snowflake, BigQuery, and your collaboration stack. Your data stays where it lives. Medable just makes it work harder.
The first time I've seen agents in clinical ops this far advanced... you're really ahead of the pack.
Agentic capabilities across your entire trial
From monitoring to document management to study builds, agentic AI capabilities save you time and protect your data quality.
Platform features
Cloud agnostic API easily integrates data
Learn the fundamental approaches and best practices to create a seamless decentralized approach for clinical trials.
Notifications and reminders
Drive adherence and ensure patients stay engaged with built-in notifications and reminders.
Connectors
MCPs connect systems like EDC, TMF, IRT, and Teams so agents surface insights in Medable Agent Space and take action across your workflows and systems.
Ontology Layer
We normalize your data so agents can deliver insights and act instantly.
Multi-study Participant app
Patients can log into any new study with Medable’s participant app available on both Apple and Google app stores. Study teams mitigate app development and deployment time getting to FPI faster.
24/7 support
Medable offers 24/7 support for trial participants and sites with a 92% first call resolution ensures that help is only a click or call away.
Reporting and dashboards
Gain a quick snapshot of your trial’s status, or deep dive into the nuances of your sites and patients, now supported by Medable AI for faster analysis.
BYOD and Provisioned Devices
Give your sites and patients the convenience and comfort they deserve with BYOD, or our 99% on-time provisioned devices.
What our customers are saying
"Everything has been remarkably smooth, which is not always the case with eCOA vendors."
Top 10 Pharma
"When it comes to modern eCOA solutions Medable is leading the pack."
Director, eClinical Development, Top 5 CRO
"Medable offered robust early engagement and SME dialogue early in planning."
Director, DCT Sourcing, Top 5 Pharma
Platform accolades
Case study: Scaling global vaccine mega-trials for a top-5 pharma
Learn how Medable enabled a top-5 pharma to scale vaccine mega-trials with near-100% enrollment, real-time safety data, and >90% diary compliance.
The latest from Knowledge Centers
Which AI and agentic AI clinical trial vendors integrate best with existing systems?
Artificial intelligence is reshaping clinical trial operations in 2026. Sponsors and CROs are no longer evaluating standalone tools. They are choosing platforms that can connect with existing systems, automate complex workflows, and scale without disrupting ongoing studies. This guide breaks down the vendors best positioned to integrate with the clinical trial infrastructure you already have.
What happened at ASCO 26?
With 44,000+ oncology professionals in attendance, ASCO 2026 may have been the most consequential in recent years. From a standing ovation for pancreatic cancer to the first positive sarcoma trial in history, here's everything that mattered at Chicago's McCormick Place this week.
Real-time clinical trials are here. Medable was built for them.
Real-time clinical trials are here. Medable's continuous trial management platform gives sponsors the evidence generation, agentic AI, and regulatory-ready infrastructure to run clinical programs at the speed the FDA now expects.